Replies to post #676837 on NorthWest Biotherapeutics Inc (NWBO)

[DrHigh]

be patient with a response. He needs to ask his handler how to answer your questions but that guy is in dispose under KG's desk at the moment

[Nemesis18]

One of the highlighted published concerns about this trial was the selection of patients, who, due to their favourable histology, resection %, genomic profile, age, tumour siting, performance status etc, had been selected over those with less promising prognosticators.
With those patients having an extended OS with or without the ‘vaccine’.
Moreover, Those with helpful MGMT status, showed a significant reduction in OS for having the vaccine. The latest European study showed that a very large % of this group had a life expectancy of 9.9 years.

Further, where is the reporting of IDH status. Another important prognosticator in the reclassification of CNS tumours.

For these and many other reasons, the Neuro Scientific community have stated that the clinical trial data is utterly un interpretable now.

As the trial took > 10years, the world & scientific understanding of Glioblastoma has moved on.

[Nemesis18]

Dr High.
May I respectfully suggest that you just stick to selling your product, rather than smoking it !

Anyway, as I step away from this forum until the NICE posts yet another update about them having to slap the Applicant around the head head abit ☝️, I’ll bid you all fair well.

Nemesis